New Strategic Partnership The International Society of Atopic Dermatitis (ISAD) is proud to announce a new exclusive strategic partnership with Umer Doctor, China’s premier professional platform for dermatologists. This collaboration marks a significant milestone as we prepare for the 16th Georg RAJKA International Symposium on Atopic Dermatitis, taking place in Beijing. Why This Partnership Matters […]
Read More
Fast runners or long-distance champions? Rethinking AD therapy trajectories➜ DOI: 10.1111/all.70395A new Allergy editorial proposes an athletic metaphor for AD therapies: JAK inhibitors as “sprinters,” IL-4/IL-13 biologics as “mid-distance runners,” and emerging immune-resetting approaches as “marathoners.” An attractive framework—but perhaps the key question is not only how therapies run, but how disease evolves in each patient. [...] Read More
Pediatric Atopic Dermatitis Guidelines in 2026:Convergence of Evidence, Divergence of Practice The recent JAAD 2026 guidelines on pediatric atopic dermatitis DOI: 10.1016/j.jaad.2026.02.114, led by the late Robert Sidbury, marks an important milestone: it is the first fully evidence-graded, pediatric-specific update in the era of biologics and JAK inhibitors. Built on a strict GRADE methodology and largely restricted […]
Read MoreAI-Powered Atopic Dermatitis Assessment: Patients Can Contribute + Small punch biopsies and non-negative matrix factorization (NMF) to study AD transcriptome + An important role of IL-22 in Th2 driven acute AD in epidermal reconstructs models + Health-Related Quality of Life in AD and Psoriasis: Are There Distinct Psychological Traits? + Towards a scientific approach of traditional Chinese medicine formulas
Read More
Are you under 35 and ready to prove your expertise in Atopic Dermatitis? The RAJKA-ISAD Symposium is calling all residents, fellows, and early-career practitioners (ECP) to step out of the clinic and into the arena. We are launching “The AD Masterminds”—a high-stakes, high-energy team tournament designed to crown the future leaders of AD care. The […]
Read More
A New Chapter in International Partnership The International Society of Atopic Dermatitis (ISAD) is pleased to announce the establishment of a The International Society of Atopic Dermatitis (ISAD) and the European Academy of Allergy and Clinical Immunology (EAACI) are proud to announce a formal strategic partnership, cemented by a Memorandum of Understanding signed in February […]
Read More
Beyond the “All-TH2” Paradigm in Atopic Dermatitis For more than two decades, atopic dermatitis (AD) has largely been interpreted through the framework of type-2 immunity. IL-4, IL-13, IgE, and eosinophils became the canonical pathway explaining disease pathogenesis and guiding therapeutic development. The remarkable clinical success of IL-4/IL-13 blockade has reinforced this paradigm. Yet both the […]
Read More
APPLY BEFORE APRIL 15! (extended) Are you an early-career dermatologist or researcher in epidemiology or public health? The ISAD-GADA Fellowship offers the chance to work with the Global Atopic Dermatitis Atlas (GADA) team, develop key research skills, and lead a small research project! The GADA team will provide state-of-the-art training in epidemiological research methodology, guiding […]
Read MoreAI-Powered Atopic Dermatitis Assessment: Patients Can Contribute + Small punch biopsies and non-negative matrix factorization (NMF) to study AD transcriptome + An important role of IL-22 in Th2 driven acute AD in epidermal reconstructs models + Health-Related Quality of Life in AD and Psoriasis: Are There Distinct Psychological Traits? + Towards a scientific approach of traditional Chinese medicine formulas
Read More
The ISAD–WHO course on atopic dermatitis in Black skin is now available, in addition to the WHO Academy platform, on the newly launched ILDS Skin Health Training Hub. Atopic Dermatitis with focus on Sub-Saharan Africa: Training for national and district-level health workers To access the course, you can either use this link https://whoacademy.org/ or type the […]
Read More